Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,655 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience.
Bagley AF, Ludmir EB, Maitra A, Minsky BD, Li Smith G, Das P, Koong AC, Holliday EB, Taniguchi CM, Katz MHG, Tamm EP, Wolff RA, Overman MJ, Patel S, Kim MP, Tzeng CD, Ikoma N, Bhutani MS, Koay EJ. Bagley AF, et al. Among authors: das p. Clin Transl Radiat Oncol. 2022 Jan 11;33:66-69. doi: 10.1016/j.ctro.2021.12.012. eCollection 2022 Mar. Clin Transl Radiat Oncol. 2022. PMID: 35097226 Free PMC article.
Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.
Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Levy LB, Ellis LM, Crane CH. Das P, et al. Am J Clin Oncol. 2006 Jun;29(3):219-24. doi: 10.1097/01.coc.0000214930.78200.4a. Am J Clin Oncol. 2006. PMID: 16755173
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.
Krishnan S, Janjan NA, Skibber JM, Rodriguez-Bigas MA, Wolff RA, Das P, Delclos ME, Chang GJ, Hoff PM, Eng C, Brown TD, Crane CH, Feig BW, Morris J, Vadhan-Raj S, Hamilton SR, Lin EH. Krishnan S, et al. Among authors: das p. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):762-71. doi: 10.1016/j.ijrobp.2006.05.063. Int J Radiat Oncol Biol Phys. 2006. PMID: 17011451 Clinical Trial.
Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater.
Krishnan S, Rana V, Evans DB, Varadhachary G, Das P, Bhatia S, Delclos ME, Janjan NA, Wolff RA, Crane CH, Pisters PW. Krishnan S, et al. Among authors: das p. Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):735-43. doi: 10.1016/j.ijrobp.2007.07.2327. Epub 2007 Nov 5. Int J Radiat Oncol Biol Phys. 2008. PMID: 17980502
Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer.
Yu TK, Bhosale PR, Crane CH, Iyer RB, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Das P. Yu TK, et al. Among authors: das p. Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1175-80. doi: 10.1016/j.ijrobp.2007.11.018. Epub 2008 Jan 22. Int J Radiat Oncol Biol Phys. 2008. PMID: 18207667 Free PMC article. Clinical Trial.
5,655 results